ALKACITRAT®, Effervescent Tablet 2 g / tab

Therapeutic indications

Indigestion (slow digestion, bloating).

Posology and method of administration

Oral use.

Dosage

For adults and children over 15 years:

1 to 3 tablets daily.

Method of administration

The effervescent tablets are dissolved in half a glass of water.

ALKACITRAT is taken before or after meals.

The duration of treatment is limited to 7 days.

Contraindications

Hypersensitivity to the active substance or to any of the excipients listed

Special warnings and precautions for use

ALKACITRAT contains 16.66 mmol sodium (or 383.2 mg) per dose. Patients on a controlled sodium diet should be considered.

Interactions with other medicines and forms of interaction

The data available to date do not indicate the existence of clinically significant interactions.

Fertility, pregnancy and lactation

Avoid during pregnancy and lactation due to lack of clinical and experimental data.

Effects on ability to drive and use machines

ALKACITRAT does not appear to affect the ability to drive and use machines.

Unwanted actions

Allergic reactions (urticaria, angioedema and rash) have been reported.

Overdose

No cases of overdose have been reported.

Pharmacodynamic properties

Pharmacotherapeutic group: Digestive and metabolic products, ATC code: A16AA06.

Betaine citrate is traditionally used to treat indigestion symptoms. This information is based solely on tradition and years of experience.

List of excipients

Mannitol, Citric acid anhydrous, Sodium bicarbonate, Raspberry flavor, Sodium saccharin, Sodium benzoate, Polyethylene glycol 6000, Starch pregelatinized.

Licence number

89058 / 10.10.2017….